Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Freeman

Showing results (321-330 of 330) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 330 results.
The Lancet. Psychiatry|September 24, 2023
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analysesDaniel Freeman, Rachel Lister, Felicity Waite, et al.
Trials|July 6, 2024
Study protocol for an adaptive, multi-arm, multi-stage (MAMS) randomised controlled trial of brief remotely delivered psychosocial interventions for people with serious mental health problems who have experienced a recent suicidal crisis: Remote Approaches to Psychosocial Intervention Delivery (RAPID)Melissa Pyle, Lucy Loftus, Richard Emsley, et al.
JAMA Network Open|June 24, 2025
Prior Expectations of Volatility Following Psychotherapy for Delusions: A Randomized Clinical TrialJulia M Sheffield, Ali F Sloan, Philip R Corlett, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Behaviour Research and Therapy|January 9, 2026
From innovation to implementation: Artificial intelligence in cognitive behaviour therapy training and supervisionRoz Shafran, Laura Bond, Per Carlbring, et al.
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Vaccines|June 24, 2022
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from AustraliaDaphne Day, Lisa Grech, Mike Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2026
Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibodyBen Tran, Mark Voskoboynik, Sang-We Kim, et al.
The Lancet. Psychiatry|September 11, 2017
The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysisDaniel Freeman, Bryony Sheaves, Guy M Goodwin, et al.
Journal for Immunotherapy of Cancer|February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Pageof 33

Showing results (321-330 of 330) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
The Lancet. Psychiatry|September 24, 2023
Automated virtual reality cognitive therapy versus virtual reality mental relaxation therapy for the treatment of persistent persecutory delusions in patients with psychosis (THRIVE): a parallel-group, single-blind, randomised controlled trial in England with mediation analysesDaniel Freeman, Rachel Lister, Felicity Waite, et al.
Trials|July 6, 2024
Study protocol for an adaptive, multi-arm, multi-stage (MAMS) randomised controlled trial of brief remotely delivered psychosocial interventions for people with serious mental health problems who have experienced a recent suicidal crisis: Remote Approaches to Psychosocial Intervention Delivery (RAPID)Melissa Pyle, Lucy Loftus, Richard Emsley, et al.
JAMA Network Open|June 24, 2025
Prior Expectations of Volatility Following Psychotherapy for Delusions: A Randomized Clinical TrialJulia M Sheffield, Ali F Sloan, Philip R Corlett, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
Behaviour Research and Therapy|January 9, 2026
From innovation to implementation: Artificial intelligence in cognitive behaviour therapy training and supervisionRoz Shafran, Laura Bond, Per Carlbring, et al.
Journal of Medicinal Chemistry|May 27, 2011
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivativesNobuko Nishimura, Aaron Siegmund, Longbin Liu, et al.
Vaccines|June 24, 2022
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from AustraliaDaphne Day, Lisa Grech, Mike Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2026
Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibodyBen Tran, Mark Voskoboynik, Sang-We Kim, et al.
The Lancet. Psychiatry|September 11, 2017
The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysisDaniel Freeman, Bryony Sheaves, Guy M Goodwin, et al.
Journal for Immunotherapy of Cancer|February 15, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)Sneha Berry, Nicolas Giraldo, Peter Nguyen, et al.
Pageof 33